ApprovalTrail

Approval · Notice of Compliance 2759 · 1998

CAPTOPRIL: Notice of Compliance 2759

Issued July 30, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
2759
Date
July 30, 1998
Company
Pharmel Inc.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Admin
Therapeutic class
Angiotensin converting enzyme inhibitor
Canadian reference product
CAPOTEN

Products in this notice

BrandDINStatus today
CAPTOPRIL02238555Cancelled Post Market
CAPTOPRIL02238556Cancelled Post Market
CAPTOPRIL02238557Cancelled Post Market
CAPTOPRIL02238558Cancelled Post Market

Medicinal ingredients